Humacyte (HUMA) Earnings Date, Estimates & Call Transcripts $4.72 +0.16 (+3.51%) Closing price 04:00 PM EasternExtended Trading$4.70 -0.02 (-0.42%) As of 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Humacyte Latest Earnings SummaryUpcoming Q4 Earnings DateMar. 20Before Market OpensEstimatedActual EPS (Nov. 8) -$0.33 Missed By -$0.08 Consensus EPS (Nov. 8) -$0.25 Humacyte posted Q3 2024 earnings on November 8, 2024, reporting an EPS of -$0.33, which missed the consensus estimate of -$0.25 by $0.08. With a trailing EPS of -$1.34, Humacyte's earnings are expected to grow next year, from ($1.27) to ($0.83) per share. Conference CallHUMA Upcoming EarningsHumacyte's next earnings date is estimated for Thursday, March 20, 2025, based off prior year's reporting schedules. Get Humacyte Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Humacyte and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataHUMA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HUMA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Humacyte Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($1.27) EPSNext Year EPS Consensus Estimate: ($0.83) EPS Humacyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 3/20/2025(Estimated)-------11/8/2024Q3 2024-$0.25-$0.33 -$0.08-$0.33--8/13/2024Q2 2024-$0.23-$0.27 -$0.04-$0.06--5/10/2024Q1 2024-$0.23-$0.29 -$0.06-$0.29--3/22/2024Q4 2023-$0.25-$0.24+$0.01-$0.24$0.10M-11/9/2023Q3 2023-$0.25-$0.25--$0.25--8/14/2023Q2 2023-$0.22-$0.22--$0.22$0.10M-5/12/2023Q1 2023-$0.22-$0.22--$0.08--3/24/2023Q4 2022-$0.24-$0.21+$0.03-$0.38-- Humacyte Earnings - Frequently Asked Questions When is Humacyte's earnings date? Humacyte has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates. Learn more on HUMA's earnings history. Did Humacyte beat their earnings estimates last quarter? In the previous quarter, Humacyte (NASDAQ:HUMA) missed the analysts' consensus estimate of ($0.25) by $0.08 with a reported earnings per share (EPS) of ($0.33). Learn more on analysts' earnings estimate vs. HUMA's actual earnings. How can I listen to Humacyte's earnings conference call? The conference call for Humacyte's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Humacyte generate each year? Humacyte (NASDAQ:HUMA) has a recorded annual revenue of $1.57 million. How much profit does Humacyte generate each year? Humacyte (NASDAQ:HUMA) has a recorded net income of -$110.78 million. HUMA has generated -$1.34 earnings per share over the last four quarters. What is Humacyte's EPS forecast for next year? Humacyte's earnings are expected to grow from ($1.27) per share to ($0.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Vera Therapeutics Earnings ImmunityBio Earnings Centessa Pharmaceuticals Earnings Harmony Biosciences Earnings Beam Therapeutics Earnings NewAmsterdam Pharma Earnings IDEAYA Biosciences Earnings Agios Pharmaceuticals Earnings Tarsus Pharmaceuticals Earnings Iovance Biotherapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:HUMA) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrillion-Dollar Crypto PlayPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humacyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
